GlassScriptPhysician profile
John M Ducey
NPI 1346507423
$8,587.82
in general payments reported to CMS, 2019-2025
53 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $869 · 2021: $1,094 · 2022: $1,347 · 2023: $1,427 · 2024: $1,386 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,185.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,524.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,025.47 | 2020-2025 | Ubrelvy, Qulipta, Vraylar |
| Lilly USA, LLC | $854.85 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $722.80 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $637.12 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $454.35 | 2019-2025 | |
| Exact Sciences Corporation | $274.00 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $257.26 | 2019-2024 | Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $256.67 | 2019-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $250.09 | 2019-2023 | Trintellix |
| Astellas Pharma US INC | $205.79 | 2019-2025 | Veozah |
| Nestle Healthcare Nutrition INC. | $144.91 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $142.12 | 2020-2024 | |
| Dexcom, INC. | $141.41 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $138.06 | 2022-2025 | Freestyle Libre 3 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ducey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.